BSE 2104.30 NSE 2104.60

Our Story

The Promise of Caring

Science can be a potent catalyst for change and transformation. This conviction in the power of science to improve health outcomes and uplift communities served as the guiding light for our founder, Dr. Desh Bandhu Gupta, and for Lupin, the company he founded in 1968.

DBG, as Dr. Gupta was fondly called, began teaching at the Birla Institute of Technology and Science in Pilani, Rajasthan, after completing his post-graduate degree in science. However, DBG had the desire to harness the power of science for his country – to bring about change and to improve healthcare in India.

Big things are often seeded in modest beginnings, and so it was for Lupin too. In 1968, DBG founded Lupin with ₹5000 borrowed from his wife. Through sheer grit, determination and perseverance, he expanded his business and soon set up Lupin’s first manufacturing plant supplying iron and folic acid tablets for the Government of India’s flagship programme aimed at improving mother and child health.

Fight Against Tuberculosis

Lupin commenced operations as a manufacturer of vitamins, and soon started producing drugs to combat tuberculosis (TB). The decision was anchored by DBG’s desire to reduce the burden of one of the most pervasive and debilitating diseases in India, despite stringent price controls on anti-TB drugs by the government.

Over the years, Lupin has grown and expanded into new areas and regions, manufacturing drugs that extend the promise of good health to communities across the globe. Beginning with two employees — a peon-cum-packer and a part-time typist — Lupin’s current global footprint spans 11 countries, across six continents. This journey has been made possible thanks to the vision and conviction of Dr. Desh Bandhu Gupta.

Who we are today

More than 55 years since DBG laid its foundation, Lupin continues to be inspired by his tenets:

  • Research as a growth driver
  • Technology as a critical differentiator to achieve world-class manufacturing standards
  • Consistent focus on quality
  • Our people as our strength
  • Caring for all our stakeholders
  • An accent on affordable, high-quality healthcare to address unmet patient needs

Did You Know?

DBG named the company after the Lupin flower

The Lupin flower can grow in harsh conditions and also nourish the soil. Inspired by nature’s example of selfless giving and resilience, DBG set up Lupin to address unmet medical needs despite the challenges on ground.

An auspicious beginning

The company was founded in 1968 on the day of Gudi Padwa, an auspicious festival celebrated in certain parts of India. Manju Gupta, DBG’s wife and our current Chairman, gave him ₹5000 to set up the business.

Lupin received its first major order from the Government of India

The company was roped in to supply iron and folic acid tablets for mother and child healthcare programmes supported by the Government of India.

The company started with two employees

Lupin’s first employees were a peon-cum-packer and a part-time typist.

Milestones

2024
16 Oct, 2024

Lupin Acquires Nine Brands of Medical Nutritional Institute in South Africa

16 Oct, 2024

Lupin Completes Acquisition of two Brands from Sanofi in Europe and Canada

16 Oct, 2024

Lupin Launches Rymti® Biosimilar Etanercept in Canada

2023
16 Oct, 2023

Lupin Acquires Five Brands from Menarini

16 Oct, 2023

Lupin Launches World’s First Fixed-dose Triple Combination Drug, Vilfuro-G® for COPD Management in India

14 Sep, 2023

Launched Luforbec® 100/6 in Germany (First-ever product launch in the inhalation segment in Germany)

18 Aug, 2023

Acquired Brands ONDERO® and ONDERO MET® from Boehringer Ingelheim International GmbH

16 Aug, 2023

Launched Spiriva (Tiotropium Dry Powder Inhaler) in the United States

18 Jul, 2023

Launched novel fixed dose triple drug combination DIFIZMA® DPI to Treat Inadequately Controlled Asthma

18 Jul, 2023

Launched LYFE, its Digital Therapeutic Solution for Holistic Heart Care